1. Home
  2. LMND vs BLLN Comparison

LMND vs BLLN Comparison

Compare LMND & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lemonade Inc.

LMND

Lemonade Inc.

HOLD

Current Price

$52.96

Market Cap

4.2B

Sector

Finance

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$96.36

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMND
BLLN
Founded
2015
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.4B
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
LMND
BLLN
Price
$52.96
$96.36
Analyst Decision
Buy
Buy
Analyst Count
7
7
Target Price
$70.86
$126.71
AVG Volume (30 Days)
947.0K
768.8K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
21.40
103.40
EPS
N/A
0.48
Revenue
$737,900,000.00
$305,112,000.00
Revenue This Year
$65.20
$46.29
Revenue Next Year
$33.31
$30.14
P/E Ratio
N/A
$192.33
Revenue Growth
40.15
99.97
52 Week Low
$46.16
$61.96
52 Week High
$99.90
$150.44

Technical Indicators

Market Signals
Indicator
LMND
BLLN
Relative Strength Index (RSI) 46.71 43.79
Support Level $52.26 $79.07
Resistance Level $54.40 $101.62
Average True Range (ATR) 1.97 4.47
MACD 0.42 0.52
Stochastic Oscillator 53.10 61.63

Price Performance

Historical Comparison
LMND
BLLN

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: